The FDA will convene an outside panel of advisers to discuss whether to allow compounding pharmacies to manufacture certain ...

CMS may change breakthrough device payments, Zealthy's legal troubles, and more.

Theresa Gaffney is the lead Morning Rounds writer and reports on health care, new research, and public policy, with a ...

Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall ...

Kennedy Jr. has a delicate task ahead of him as he heads to Capitol Hill to testify about the fiscal 2027 budget request: ...

Roche is launching a Phase 3 trial of the controversial Duchenne gene therapy Elevidys, hoping it could lead to approval in ...

The Centers for Medicare and Medicaid Services is proposing to repeal a pathway that currently allows breakthrough devices to ...

The FDA will convene an outside panel of advisers to discuss whether to allow compounding pharmacies to manufacture certain ...

The DOJ’s Weaponization Working Group — a purportedly apolitical effort to weed out politically motivated actions within the ...

Revolution Medicines $2B fundraise, Structure's new hire hints at acquisition efforts, and more Readout biotech news ...

New AI tools could screen existing CT scans to asses risk for heart disease. But, who'll pay for it, and will it improve ...

Y ou’re reading the web edition of STAT’s AI Prognosis newsletter, our subscriber-exclusive guide to artificial intelligence ...